Carregant...
Androgen deprivation therapy for prostate cancer is associated in increased risk for biliary disease
BACKGROUND: Androgen deprivation therapy (ADT) for prostate cancer produces benefits in several clinical situations but has adverse metabolic effects including obesity, increased abdominal girth, increased triglycerides, and insulin resistance. Each of these is a risk factor for gallstone disease. A...
Guardat en:
| Publicat a: | Eur Urol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4535925/ https://ncbi.nlm.nih.gov/pubmed/23428068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2013.02.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|